Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Orlova, A. Lavrushin (Saint-Petersburg, Russian Federation). Chemical and hard metal induced exogenous toxic alveolitis (ETA) (follow up 1,5 years). Eur Respir J 2013; 42: Suppl. 57, 2358

Member's Comments

No comment yet.

Related content which might interest you: Clara cell protein 16 (CC16) and markers of fibrosis in exogenous toxic (ETA) and exogenous allergic (EAA) alveolites Source: International Congress 2014 – Environment and mechanisms Year: 2014 Pulmonary alveolar proteinosis (PAP) in exogenous toxic alveolitis (ETA) patients Source: International Congress 2015 – Occupational disease: clinical cases and series Year: 2015 Radiological and morphological patterns in pneumoconiosis (PC) and exogenous toxic alveolitis (ETA) Source: Eur Respir J 2001; 18: Suppl. 33, 528s Year: 2001 Radiographic changes in patients with tumor necrosis factor alpha inhibitor and immunomodulatory drug users: Four years follow up Source: International Congress 2016 – Mixed-up imaging of various chest diseases Year: 2016 Sarcoidosisandpulmonarydust: Mineralogical analysis (MA) and optical microscopy (OM) Source: International Congress 2014 – Sarcoidosis Year: 2014 Use of acetylcysteinein the treatment of patients with exogenic allergic alveolitis (EAA) Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013 A mechanism for acceleration of GM-CSF autoantibody (GMAb) production in autoimmune pulmonary alveolar proteinosis (aPAP) Source: International Congress 2014 – Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD) Year: 2014 Progressive fibrotic phenotype in exogenous toxic alveolitis (ETA) Source: Virtual Congress 2020 – Occupational exposure as a cause of respiratory disease Year: 2020 Pirfenidone suppresses proinflammatory and antiangiogenetic cytokine production by alveolar macrophages (AMs) in idiopathic non specific interstitial pneumonia (iNSIP) Source: International Congress 2014 – ILDs 2 Year: 2014 LATE-BREAKING ABSTRACT: Morphology and molecular basis of damage stem cell niche respiratory acini (SCNRA) in idiopathic interstitial pneumonia (IIP) Source: International Congress 2016 – Common mechanisms in lung development and fibrosis Year: 2016 Usefulness of a myositis antibody immunoblot in diagnosis of connective tissue disease (CTD) related interstitial lung disease (ILD) Source: International Congress 2014 – ILDs 4 Year: 2014 Lung structure and function relation in systemic sclerosis: Application of lung densitometry Source: International Congress 2015 – A more functional view of chest pathology Year: 2015 Diagnostic aspects of exogenous toxic alveolitis (ETA), due to polymetallic aerosols Source: Eur Respir J 2005; 26: Suppl. 49, 542s Year: 2005 Effect of nintedanib on the release of angiogenic/angiostatic cytokines by alveolar macrophages (AMs) in interstitial lung diseases (ILD) Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 Difference in immunological aspects of inflammation in idiopathic pulmonary fibrosis (IPF) and exogenous toxic alveolitis (ETA) Source: Eur Respir J 2003; 22: Suppl. 45, 121s Year: 2003 Detection of anti DFS70 antibodies in patients with interstitial lung disease (ILD) with and without connective tissue disease (CTD) Source: International Congress 2016 – Connective tissue disorders Year: 2016 Enhanced apoptosis of alveolar lymphocytes (AL), but not macrophages (AM) in interstitial idiopathic pneumonias (IIPs). Special attention to idiopathic pulmonary fibrosis (IPF) results Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010 Effect of cigarette smoking on alveolar macrophages (AM) and lymphocytes (AL) apoptosis in selected interstitial lung diseases (ILD) Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease Year: 2008 Chemical exposure triggering connective tissue disease with lung involvement Source: International Congress 2015 – Occupational disease: clinical cases and series Year: 2015 Idiopathic non-specific interstitial pneumonia (iNSIP): do the patients develop connective tissue disease (CTD) during follow-up? Source: International Congress 2016 – Connective tissue disorders Year: 2016